Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (91-100 of 1,364) with videos related to

Pageof 137
Sort By:
Ejhaem|July 18, 2022
Real-world treatment patterns, adverse events and clinical outcomes in patients with chronic lymphocytic leukaemia treated with ibrutinib in the UKPeter Hillmen, Jing Xie, Alan S M Yong, et al.
Ejhaem|July 18, 2022
An open-source, expert-designed decision tree application to support accurate diagnosis of myeloid malignanciesThomas Coats, Daniel Bean, Theodora Vatopoulou, et al.
Ejhaem|July 18, 2022
The importance of retaining physical functions to prevent skeletal-related events in multiple myeloma patients with bone diseaseHirokazu Miki, Shingen Nakamura, Masahiro Oura, et al.
Ejhaem|July 18, 2022
Phenotypic switching to hypereosinophilia during cytoreductive therapy for transient abnormal myelopoiesis associated with Down syndromeKenichiro Kobayashi, Asami Watanabe, Shumpei Mizuta, et al.
Ejhaem|July 18, 2022
Hemophagocytosis by acute myeloid leukemia blasts associated to poor clinical outcomesZangbéwendé Guy Ouedraogo, Victoria Cacheux, Louis-Thomas Dannus, et al.
Ejhaem|July 18, 2022
Refractory immune thrombocytopenic purpura associated with IgM monoclonal gammopathy of undetermined significance: Successful treatment with tirabrutinib plus conventional therapiesRyosuke Naka, Hitomi Kaneko, Osamu Nagata, et al.
Ejhaem|July 18, 2022
Colonic myeloid sarcoma with mutated <i>NPM1</i> manifesting with ulcerationMehrnoosh Tashakori, Joseph D Khoury
Ejhaem|July 18, 2022
Localized skin-limited blastic plasmacytoid dendritic cell neoplasmEdwin U Suárez, Javier Cornago, Miguel Á Piris, et al.
Ejhaem|July 18, 2022
First-line treatment of stage IIB to stage IV classical Hodgkin lymphoma in Italy, Israel, and Spain: Patient characteristics, treatment patterns, and clinical outcomesAbraham Avigdor, Fabrizio Trinchese, Francois Gavini, et al.
Ejhaem|July 18, 2022
A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignanciesJoan How, Siyang Ren, Jennifer Lombardi-Story, et al.
Pageof 137

Showing results (91-100 of 1,364) with videos related to

Sort By:
Pageof 137
Ejhaem|July 18, 2022
Real-world treatment patterns, adverse events and clinical outcomes in patients with chronic lymphocytic leukaemia treated with ibrutinib in the UKPeter Hillmen, Jing Xie, Alan S M Yong, et al.
Ejhaem|July 18, 2022
An open-source, expert-designed decision tree application to support accurate diagnosis of myeloid malignanciesThomas Coats, Daniel Bean, Theodora Vatopoulou, et al.
Ejhaem|July 18, 2022
The importance of retaining physical functions to prevent skeletal-related events in multiple myeloma patients with bone diseaseHirokazu Miki, Shingen Nakamura, Masahiro Oura, et al.
Ejhaem|July 18, 2022
Phenotypic switching to hypereosinophilia during cytoreductive therapy for transient abnormal myelopoiesis associated with Down syndromeKenichiro Kobayashi, Asami Watanabe, Shumpei Mizuta, et al.
Ejhaem|July 18, 2022
Hemophagocytosis by acute myeloid leukemia blasts associated to poor clinical outcomesZangbéwendé Guy Ouedraogo, Victoria Cacheux, Louis-Thomas Dannus, et al.
Ejhaem|July 18, 2022
Refractory immune thrombocytopenic purpura associated with IgM monoclonal gammopathy of undetermined significance: Successful treatment with tirabrutinib plus conventional therapiesRyosuke Naka, Hitomi Kaneko, Osamu Nagata, et al.
Ejhaem|July 18, 2022
Colonic myeloid sarcoma with mutated <i>NPM1</i> manifesting with ulcerationMehrnoosh Tashakori, Joseph D Khoury
Ejhaem|July 18, 2022
Localized skin-limited blastic plasmacytoid dendritic cell neoplasmEdwin U Suárez, Javier Cornago, Miguel Á Piris, et al.
Ejhaem|July 18, 2022
First-line treatment of stage IIB to stage IV classical Hodgkin lymphoma in Italy, Israel, and Spain: Patient characteristics, treatment patterns, and clinical outcomesAbraham Avigdor, Fabrizio Trinchese, Francois Gavini, et al.
Ejhaem|July 18, 2022
A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignanciesJoan How, Siyang Ren, Jennifer Lombardi-Story, et al.
Pageof 137